Three Square Market hopes to use its microchipping technologies for vulnerable patients
A leader in micro market technology, servicing markets in North America, Europe, Asia and Australia, Three Square Market has been infamous in microchipping willing employees, and is set to take its technology to the next level.
Developing a new chip which will be powered by body heat, according to CNBC, the business will harness GPS technology and voice recognition software, and are looking to utilise the technology to support the healthcare sector and give vulnerable patients and their families greater reassurance.
At present, employees can use their RFID chip to open doors, log in to computers, and purchase snacks, with no GPS technology placed within the software.
If approved by the Food and Drug Administration (FDA), the new chip could become a potential gamechanger.
- GlucoMe and Merck partner in a new digital diabetes management project
- Top 10 healthcare disruptors
- Life science supply chain firm Tracelink raises $93mn in new funding
"It's not only GPS and voice activation, it's working on monitoring your vital signs, and there are different medical institutions that obviously want that," said Patrick McMullan, President of Three Square Market and chip technology business Three Square Chip.
The technology could provide greater support to those with dementia and Alzheimer’s and provide a greater support to families and care givers.
In the upcoming months, the company has confirmed to Technology Review that it will be working with two hospitals, where healthcare professionals will be given chipped bracelets to wear, which will note when they are washing their hands, as a basic trial.
"You see a lot of discussion now about implants, and how they can take your heartbeat, get your blood glucose levels — you see Amazon just hiring a top-notch doctor, you see Walmart filing for patents on this.
“What we've really done is made it acceptable, or brought it to the forefront where people are now talking about it and looking at the benefits it can do for a person," added Three Square Market Chief Executive Officer, Todd Westby.
NeuTigers: edge AI in healthcare
What is edge AI?
Edge AI is essentially a combination of edge computing and artificial intelligence. Algorithms are processed locally - directly on a mobile device or server - rather than in the cloud. This reduces cost, computing power and energy requirements. There are also claims that edge AI is so fast it is possible to reach near real-time analytics.
Edge AI devices include smart speakers, smart phones, laptops, robots, self-driven cars, drones, and surveillance cameras that use video analytics.
Who is NeuTigers?
NeuTigers is a spin-off company from Princeton University, formed in 2018 to apply edge AI and machine learning to solve challenges in healthcare, energy, productivity, and security.
With offices in Princeton, NJ, the company is based at one of the top AI accelerator programs of FutureLabs in New York, and has also established a subsidiary in Nice, France.
How is NeuTigers applying edge AI to healthcare?
The NeuTigers AI Technology Stack uses deep neural networks that mimic how the human brain perceives and interprets the world. The company has developed the StarDeepTM Smart Health Platform for health monitoring and biomedical imaging, to improve the accuracy and speed of diagnosing diseases.
NeuTigers say the platform has the potential to monitor and screen for thousands of conditions, when used in combination with medical devices and smart sensors already deployed in healthcare settings.
Are there any real world examples?
In January NeuTigers launched CovidDeep, a tool that predicts COVID-19 with more than 90% accuracy, using physiological data from a wristband along with blood pressure and blood oxygen readings. It then analyses the data and gives a prediction within two minutes.
This week NeuTigers announced a new study to detect the early signs of complications with sickle cell anaemia. Conducted at a hospital in Paris, the research will begin by looking at changes to skin response, heart beat, sleep and temperature to predict an acute episode of sickle cell anaemia, and how this impacts on the patients’ disease conditions and quality of life.
The second phase of the project is to expand with prospective studies across different sites in EU, Africa and the US to explore the models' accuracy and clinical effectiveness.
Adel Laoui, CEO and founder of NeuTigers, says: “The best way to deal with a crisis is to avoid it happening in the first place. We are now entering a new era where medical early warning systems have become a reality.
“We are excited at the possibility of deploying a technology that can save lives of patients dealing with sickle cell anaemia. The potential of the StarDeep platform to dramatically improve patient outcomes while slashing some of the highest costs of healthcare makes it one of the most exciting developments in preventative personal medicine.”